日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

外泌体介导的肿瘤相关巨噬细胞基因重编程(由 exoASO-STAT6 实现)可产生强大的单一疗法抗肿瘤活性

Sushrut Kamerkar, Charan Leng, Olga Burenkova, Su Chul Jang, Christine McCoy, Kelvin Zhang, Kevin Dooley, Samuel Kasera, Tong Zi, Sílvia Sisó, William Dahlberg, Chang Ling Sia, Shil Patel, Karl Schmidt, Kyriakos Economides, Timothy Soos, Dalia Burzyn, Sriram Sathyanarayanan